BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 22425402)

  • 1. Predictors of long-acting reversible contraception use among unmarried young adults.
    Dempsey AR; Billingsley CC; Savage AH; Korte JE
    Am J Obstet Gynecol; 2012 Jun; 206(6):526.e1-5. PubMed ID: 22425402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends and determinants of use of long-acting reversible contraception use among young women in France: results from three national surveys conducted between 2000 and 2010.
    Moreau C; Bohet A; Hassoun D; Teboul M; Bajos N;
    Fertil Steril; 2013 Aug; 100(2):451-8. PubMed ID: 23663994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of users of intrauterine devices and other reversible contraceptive methods in the United States.
    Xu X; Macaluso M; Frost J; Anderson JE; Curtis K; Grosse SD
    Fertil Steril; 2011 Nov; 96(5):1138-44. PubMed ID: 21917255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of use of long-acting reversible methods of contraception among adolescent and young adult women.
    Whitaker AK; Dude AM; Neustadt A; Gilliam ML
    Contraception; 2010 Apr; 81(4):299-303. PubMed ID: 20227545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge and Acceptability of Long-Acting Reversible Contraception Among Adolescent Women Receiving School-Based Primary Care Services.
    Hoopes AJ; Ahrens KR; Gilmore K; Cady J; Haaland WL; Amies Oelschlager AM; Prager S
    J Prim Care Community Health; 2016 Jul; 7(3):165-70. PubMed ID: 27067583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitudes toward long-acting reversible contraception among young women seeking abortion.
    Rose SB; Cooper AJ; Baker NK; Lawton B
    J Womens Health (Larchmt); 2011 Nov; 20(11):1729-35. PubMed ID: 21923281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the intrauterine device among adolescent and young adult women in the United States from 2002 to 2010.
    Whitaker AK; Sisco KM; Tomlinson AN; Dude AM; Martins SL
    J Adolesc Health; 2013 Sep; 53(3):401-6. PubMed ID: 23763968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postabortion Initiation of Long-Acting Reversible Contraception by Adolescent and Nulliparous Women in New Zealand.
    Rose SB; Garrett SM
    J Adolesc Health; 2016 Feb; 58(2):160-6. PubMed ID: 26603946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Awareness and knowledge of the intrauterine device in adolescents.
    Barrett M; Soon R; Whitaker AK; Takekawa S; Kaneshiro B
    J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):39-42. PubMed ID: 22051791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with short interpregnancy interval in women who plan postpartum LARC: a retrospective study.
    Harney C; Dude A; Haider S
    Contraception; 2017 Mar; 95(3):245-250. PubMed ID: 27589883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long acting reversible contraception in postpartum adolescents: early initiation of etonogestrel implant is superior to IUDs in the outpatient setting.
    Tocce K; Sheeder J; Python J; Teal SB
    J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):59-63. PubMed ID: 22051792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting reversible contraception (LARC) use among adolescent females in secondary institutions in Nnewi, Nigeria.
    Eke AC; Alabi-Isama L
    J Obstet Gynaecol; 2011; 31(2):164-8. PubMed ID: 21281035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peer counselling for the promotion of long-acting, reversible contraception among teens: a randomised, controlled trial.
    Wilson SF; Degaiffier N; Ratcliffe SJ; Schreiber CA
    Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):380-7. PubMed ID: 27499054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to Recommended Practices for Provision of Long-Acting Reversible Contraception Among Providers in a Large U.S. Health Care System.
    Judge-Golden CP; Wiesenfeld HC; Chen BA; Borrero S
    J Womens Health (Larchmt); 2020 Dec; 29(12):1586-1595. PubMed ID: 32667847
    [No Abstract]   [Full Text] [Related]  

  • 15. Examining quality of contraceptive services for adolescents in Oregon's family planning program.
    Rodriguez MI; Darney BG; Elman E; Linz R; Caughey AB; McConnell KJ
    Contraception; 2015 Apr; 91(4):328-35. PubMed ID: 25545334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Awareness of long-acting reversible contraception among teens and young adults.
    Teal SB; Romer SE
    J Adolesc Health; 2013 Apr; 52(4 Suppl):S35-9. PubMed ID: 23535055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IUD use in France: women's and physician's perspectives.
    Moreau C; Bohet A; Hassoun D; Ringa V; Bajos N;
    Contraception; 2014 Jan; 89(1):9-16. PubMed ID: 24239330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of contraceptive choice on rapid repeat pregnancy.
    Sackeim MG; Gurney EP; Koelper N; Sammel MD; Schreiber CA
    Contraception; 2019 Mar; 99(3):184-186. PubMed ID: 30471261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting reversible contraception: Findings from the Understanding Fertility Management in Contemporary Australia survey.
    Holton S; Rowe H; Kirkman M; Jordan L; McNamee K; Bayly C; McBain J; Sinnott V; Fisher J
    Eur J Contracept Reprod Health Care; 2016; 21(2):116-31. PubMed ID: 26043118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceptions of long-acting reversible contraception among women receiving medication for opioid use disorder in Vermont.
    Rey CN; Badger GJ; Melbostad HS; Wachtel D; Sigmon SC; MacAfee LK; Dougherty AK; Heil SH
    Contraception; 2020 May; 101(5):333-337. PubMed ID: 32014521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.